Materias dentro de su búsqueda.
Mostrando 68,581 - 68,600 Resultados de 68,694 Para Buscar 'Funny OR Die', tiempo de consulta: 0.51s Limitar resultados
  1. 68581
    “…PROBLEM/CONDITION: In 2014, approximately 59,000 persons died in the United States as a result of violence-related injuries. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Surveillance for Violent Deaths —
National Violent Death Reporting System, 18 States, 2014
  2. 68582
    “…By 24 weeks, 97/902 (10.9%) raltegravir-intensified ART versus 91/903 (10.2%) standard ART participants had died (adjusted hazard ratio [aHR] = 1.10 [95% CI 0.82–1.46], p = 0.53), with no evidence of interaction with other randomisations (p(heterogeneity) > 0.7) and despite significantly greater VL suppression with raltegravir-intensified ART at 4 weeks (343/836 [41.0%] versus 113/841 [13.4%] with standard ART, p < 0.001) and 12 weeks (567/789 [71.9%] versus 415/803 [51.7%] with standard ART, p < 0.001). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial
  3. 68583
    “…She reported significant pregnancy morbidity having given birth to a daughter with multiple congenital abnormalities who unfortunately died two days after birth. She suffered 4 subsequent miscarriages at 5-7 weeks gestation with the same partner and underwent extensive genetic testing. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    9. Successful use of IL-6 pathway blockade to treat autoinflammation occurring in the context of a novel TNFRS1A gene mutation
  4. 68584
    “…Six (4%) patients in the hIVIG group and five (3%) in the placebo group died, but these deaths were not necessarily related to treatment. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial
  5. 68585
    “…RESULTS: Of 5125 hospitalized older adults, 15% were non-frail, 39% pre-frail, 40% frail, and 6% most frail. 11% died, and poor recovery was experienced by 520/4544=11% of survivors. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Frailty Hinders Recovery From Acute Respiratory Illness in Older Adults
  6. 68586
    “…METHODS: In this single-centered, retrospective, observational study, we enrolled 125 patients with COVID-19 who were died between January 13 and March 4, 2020 in Renmin Hospital of Wuhan University. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Abnormal immunity of non-survivors with COVID-19: predictors for mortality
  7. 68587
    “…Six (1%) of 627 patients died in hospital, all of whom had profound comorbidity. 11% (52/456) met the WHO MIS-C criteria, with the first patient developing symptoms in mid-March. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study
  8. 68588
    “…Out of the 4464 patients, 869 patients died, 2 of which received treatment with biological agents. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
  9. 68589
    “…At baseline, older age, higher SAPS II scores, male sex, smoking or alcohol abuse, use of vasopressors on day 1, and invasive mechanical ventilation on day 1 were independently associated with fewer days alive and free of delirium and coma (all p<0·01). 601 (28·8%) of 2088 patients died within 28 days of admission, with most of those deaths occurring in the ICU. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study
  10. 68590
    “…Among 262 patients admitted to hospital with seasonal hCoV infection and with complete information on potential risk factors, 66 (73·3%) of 90 patients who had complications or died also had at least one potential risk factor (p=0·0064). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015–20: a surveillance study
  11. 68591
    “…Three patients with stage 1 g-HAT died after the 10 day treatment period and before the 12 month primary follow-up visit, considered as treatment failure and were withdrawn from the study. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study
  12. 68592
    “…In-hospital mortality was 57·7% (1101/1909 patients) and ICU mortality was 57·0% (1088/1909 patients); 462 (43·8%) patients died of refractory hypoxaemia, frequently overlapping with septic shock (n=174). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study
  13. 68593
    “…After a median follow-up of 6.1 months (range, 0.5-13.6 months), the mortality rate was 16% in all patients and 28% in allogeneic HCT recipients. Among 9 patients who died, the median survival after SARS-CoV-2 infection was 23 days (range, 14 to 140 days). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients
  14. 68594
    “…A total of 324 patients were enrolled in the Mayo Expanded Access Program, and 116 patients were excluded: 4 (3%) were transferred to outside hospitals, 27 (23%) died before CCP transfusion (when resources were scarce), 5 (4%) had more than 14 days of symptoms onset, 64 (55%) were discharged before CCP infusion, and 36 patients were waiting for plasma transfusion. 172 patients received convalescent plasma, including 12 patients (6.9%) that received two units of CCP. 114 (66%) discharged. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Leveraging the Power of a Healthcare System to Fulfill the COVID Convalescent Plasma Needs Early in the COVID-19 Pandemic
  15. 68595
    “…A median of 7 visits per patient (4-14) were required until day +100 or last follow-up in the outpatient clinic and complemented with 4 (1-18) telemedicine consults. No one died from transplant related mortality. No cases of COVID19 were documented. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Outpatient Transplantation during the COVID19 Pandemic: Stretching the Limits for Continuing Care
  16. 68596
    “…COVID-19 is a pandemic affecting many countries globally.(1) As of 23(rd) July 2020, there have been 297,146 lab-confirmed cases of COVID-19 in the UK and 45,554 people who tested positive for the virus have died.(2) Patients with multiple myeloma (MM) are at a higher risk of contracting the virus and experiencing more severe outcomes.(3-6) The higher risk is driven by a compromised immune system, the use of immunosuppressive agents and patient characteristics aligning with key risk factors - patients with MM are often elderly and have multiple co-morbidities.(7) In light of the COVID-19 outbreak, NHS England and NICE have issued guidance to modify usual care to reduce patient exposure to COVID-19. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Delivering Systemic Anti-Cancer Treatment Via Another Route of Administration As an Option to Reduce Exposure to COVID-19 in Patients with Multiple Myeloma in the UK
  17. 68597
    “…Correspondingly, a total of 19 of the 146 patients without SCT died in the hospital (13%), compared to 3 of 20 SCT patients (15%), Fisher exact test p-value = 0.732, despite the difference in the groups at admission. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact of Sickle Cell Trait on Morbidity and Mortality from Sars-Cov-2 Infection
  18. 68598
    “…During follow-up, a total of 21 patients died, representing 6.5% of the study population. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Impact of Different Prophylactic Anticoagulation Doses on the Outcomes of Patients with COVID-19
  19. 68599
    “…In this secondary analysis of maternal deaths in CLIP, we included women who died in any of the 22 intervention clusters or 22 control clusters. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Causes and circumstances of maternal death: a secondary analysis of the Community-Level Interventions for Pre-eclampsia (CLIP) trials cohort
  20. 68600
    “…Of seven serious adverse events, one severe fever in a HIV-negative participant was definitely related to trial intervention and one severely elevated alanine aminotranferase in a participant with HIV was unlikely related; five others were deemed unrelated. One person with HIV died (unlikely related). People with HIV and HIV-negative participants showed vaccine-induced serum IgG responses against wild-type Wuhan-1 Asp614Gly (also known as D614G). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial
Herramientas de búsqueda: RSS